Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brandon Lawrence

Orthopaedic Surgery Salt Lake City, UT Medical Doctor

NPI 1659555670 CMS profile 1151028

590 Wakara Way, Salt Lake City, UT 84108

Open in the dashboard

General payments

$143,683

177 records reported · program years 2019–2025

Research payments

$266,507

Paid to them · 6 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,756,855 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Brandon Lawrence of Salt Lake City, UT is reported in the CMS Open Payments database as having received $143,683 across 177 general payments and $266,507 in research payments paid to them. Separately, studies naming them as principal investigator received $1,756,855 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $76,515 65
2024 General $36,804 67
2024 Research $266,507 6
2023 General $12,619 22
2022 General $7,922 10
2021 General $6,097 8
2019 General $3,726 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brandon Lawrence
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Brandon Lawrence were reported at $76,515. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Brandon Lawrence Orthopaedic Surgery median Middle half National median
2019 $3,726 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $6,097 $520 $117–$2,495 $132
2022 $7,922 $598 $128–$2,731 $149
2023 $12,619 $461 $128–$2,264 $160
2024 $36,804 $497 $134–$2,475 $164
2025 $76,515 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $39,728 44 payments
  2. Kuros Biosciences USA, Inc $37,931 29 payments
  3. Highridge Medical LLC $27,271 38 payments
  4. Medical Device Business Services, Inc. $22,698 21 payments
  5. Zimvie Inc. $8,534 17 payments
  6. Synthes GmbH $5,309 7 payments
  7. DePuy Synthes Products, Inc. $571 2 payments
  8. Alphatec Spine, Inc $405 2 payments
  9. DePuy Synthes Sales Inc. $328 3 payments
  10. Stryker Corporation $224 4 payments
  11. Other $684 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $95,403 37 payments
  2. Travel and Lodging $29,916 54 payments
  3. Royalty or License $6,520 1 payment
  4. Food and Beverage $4,881 76 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,150 2 payments
  6. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $2,000 1 payment
  7. Compensation for serving as faculty or as a speaker for a medical education program $1,750 4 payments
  8. Entertainment $64 2 payments
Products named General payments · program years 2019–2025
  1. MAGNETOS $37,907 28 payments
  2. Virage $28,322 46 payments
  3. INFUSE BONE GRAFT $23,665 24 payments
  4. GRAFTONAND GRAFTON PLUSDEMINERALIZED BONE MATRIX (DBM) $9,597 11 payments
  5. Spine-None $6,983 7 payments
  6. INFUSE $2,400 2 payments
  7. MASTERGRAFT $2,400 1 payment
  8. Velys $571 2 payments
  9. Vital $327 1 payment
  10. LIF $250 1 payment
  11. Other $1,435 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Eli Lilly and Company $266,507 6 payments

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$315,317

Medicare's payments for the services billed

Medicare patients

301

Average age 73

Services billed

1,263

155 women, 146 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Depression 35%
Diabetes 26%
Ischemic heart disease 25%
Chronic kidney disease 23%
Osteoporosis 18%
Cancer 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

183 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record